ZIMLAB · Zim Laboratories Limited · Financials
Market Cap
7.56B INR
Shares
53.66M
Volume · Nov 13
63.85K
Avg daily vol (3M)
138.45K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
3.74B
-1.2%
FY2026
Net Income
58.38M
-52%
FY2026
Operating Cash Flow
495.34M
+20.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| INR | 4.14B | 3.74B | 3.79B | 3.67B | 3.99B |
| INR | 220.36M | 199.78M | 201.13M | 159.52M | 174.69M |
| INR | 143.2M | 132.02M | 113.88M | 69.24M | 55.75M |
| INR | 26.78M | 82.13M | 180.09M | 236.42M | 353.55M |
| INR | 6.07M | 23.75M | 58.44M | 63.96M | 109.21M |
| INR | 20.71M | 58.38M | 121.65M | 172.46M | 244.35M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.